Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc switch for proteinuria in HIV-1 patients (MARCHrenal)
NCT01637259Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Jun 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Jun 2012; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01637259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637259.